Harish Seethamraju, M.D.,at montefiore and einstei

Harish Seethamraju, M.D.,at montefiore and einstein "By calming the overactive immune systems of these patients, leronlimab halted the inflammation and blood clotting that are so damaging to the lungs, liver and kidneys of severely ill COVID-19 patients," said Dr. Seethamraju. All 10 patients had extremely high blood levels of CCL5, which are inflammatory molecules known as cytokines. This is why the extreme inflammatory response is known as the "cytokine storm."

https://www.prnewswire.com/news-releases/a-pr...63687.html